Asian Fund for Cancer Research Limited (AFCR) shared a post on LinkedIn:
“Asian Fund for Cancer Research Limited is proud to serve as a supporting organization for BIOHK2026, the Hong Kong International Biotechnology Conference and Exhibition.
Taking place September 9–12, 2026, in Hong Kong, BIOHK2026 will bring together leaders and innovators across biotechnology, healthcare, and life sciences. Join us in supporting knowledge exchange, cross-sector collaboration, and innovation that can help drive progress in cancer research.”
Other articles about Asian Fund for Cancer Research Limited on OncoDaily.